(Q35495620)

English

Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator System

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator System (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

ChEBI release 2020-05-28

author name string

Jennifer C Carter

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Frank C Church

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

29 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Journal of oncology

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

2011

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

594258

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Enhanced cell-associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Does the inhibition of c-myc expression mediate the anti-tumor activity of PPAR's ligands in prostate cancer cell lines?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Diet, Body Weight, and Colorectal Cancer: A Summary of the Epidemiologic Evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Nutrition and diet in the development of gastrointestinal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Induction of plasminogen activator inhibitor 1 gene expression in adipocytes by thiazolidinediones.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Terminal differentiation of human breast cancer through PPAR gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Xenograft model of progressive human proliferative breast disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

27 July 2018

Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Peroxisome Proliferator-Activated Receptor-gamma Is a Potent Target for Prevention and Treatment in Human Prostate and Testicular Cancer

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Food groups and colon cancer risk in African-Americans and Caucasians.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Plasminogen activator inhibitor type 1 is the most significant of the usual tissue prognostic factors in node-negative breast ductal adenocarcinoma independent of urokinase-type plasminogen activator.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Bezafibrate attenuates the overexpression of plasminogen activator inhibitor-1 messenger RNA by a combination of mono-unsaturated fatty acid and insulin in hepG2 cells

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive ox

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F594258

21 January 2018

Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

26 September 2018

Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

26 September 2018

The increase in plasminogen activator inhibitor type-1 expression by stimulation of activators for peroxisome proliferator-activated receptors in human endothelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205730

26 September 2018

Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22131991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22131991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/22131991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22131991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential transcriptional activation of peroxisome proliferator-activated receptor gamma by omega-3 and omega-6 fatty acids in MCF-7 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22131991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22131991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of PPAR-gamma agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22131991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer risk factors and second primary malignancies among women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22131991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mammary tumor stimulatory factors as well as mammastatin are produced by the normal human breast epithelial cell line MCF10A

1 reference

https://pubmed.ncbi.nlm.nih.gov/22131991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2011/594258

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35495620&oldid=1801531430"